Clinical Trials in San Francisco

Showing 5761-5780 of 12,991 trials

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

NCT05572463

This is a platform study evaluating the safety and efficacy of multiple novel investigational products (IPs) that target unresectable or metastatic cutaneous melanoma in participants who have failed standard treatment.

Unresectable Cutaneous MelanomaMetastatic Cutaneous Melanoma

Innovent Biologics (Suzhou) Co. Ltd.Started Nov 2022

San Francisco, California, United States • Detroit, Michigan, United States • Hackensack, New Jersey, United States +10 more locations

Active Not RecruitingNA< 1 mile

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

NCT02732704

To collect information about treatment for severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may include fatigue and shortness of breath. The preferred treatment for severe aortic regurgitation is aortic valve replacement surgery.

Aortic Regurgitation

JenaValve Technology, Inc.100 participantsStarted Apr 2018

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +16 more locations

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

Find Trials by Condition in San Francisco

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

TruGraf® Long-term Clinical Outcomes Study

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

An Active Approach to Treat Amblyopia: Perceptual Learning and Video Games

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy

Novel Clinical Target in Fragile X Syndrome

OPEN & ASK: Improving Patient-Centered Communication in Primary Care

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

Vascular Inflammation in Psoriasis - Apremilast

Predictive Assay for Decision Making in Adjuvant Therapy

A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands